Evolent Announces Fourth Quarter and Full Year 2023 Results [Yahoo! Finance]
Evolent Health, Inc Class A (EVH)
Last evolent health, inc class a earnings: 2/25 04:02 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.evolenthealth.com
Company Research
Source: Yahoo! Finance
Adjusted EBITDA of $194.7 million , 84% growth over 2022 2023 cash flow from operations of $142.6 million Provides initial outlook for 2024 in line with long-term targets WASHINGTON Feb. 22, 2024 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company that specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable, today announced financial results for the three months and year ended December 31, 2023. Seth Blackley , Chief Executive Officer, and Co-Founder of Evolent stated, "We ended 2023 on a strong note, achieving all of our financial objectives for the year. Annual revenue increased over 45% while we continued to deliver strong earnings, driven by continued underlying growth as well as the successful integration of NIA. I am incredibly proud of our global team who worked so hard to collectively deliver what we promised to both shareholders and partners in 2023. Our financial posi
Show less
Read more
Impact Snapshot
Event Time:
EVH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EVH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EVH alerts
High impacting Evolent Health, Inc Class A news events
Weekly update
A roundup of the hottest topics
EVH
News
- Evolent Health, Inc. (NYSE: EVH) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $40.00 price target on the stock.MarketBeat
- Evolent To Release First Quarter 2024 Financial Results on Thursday, May 9, 2024PR Newswire
- Exclusive: Inside Wiz's acquisition of Gem Security [Fortune]Fortune
- Define Ventures Welcomes Frank Williams as Venture Partner [Yahoo! Finance]Yahoo! Finance
- Recent 7.4% pullback isn't enough to hurt long-term Evolent Health (NYSE:EVH) shareholders, they're still up 134% over 5 years [Yahoo! Finance]Yahoo! Finance
EVH
Earnings
- 2/22/24 - Beat
EVH
Sec Filings
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- EVH's page on the SEC website